The role of economic evaluation in the pricing and reimbursement of medicines
- 15 June 1997
- journal article
- research article
- Published by Elsevier in Health Policy
- Vol. 40 (3) , 199-215
- https://doi.org/10.1016/s0168-8510(97)00901-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pricing and Reimbursement of Pharmaceuticals in SwedenPharmacoEconomics, 1994
- The Emerging Government Requirement for Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1994
- New Developments in Pricing and Drug Reimbursement in FrancePharmacoEconomics, 1994
- Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1993
- Pricing, Profits, and Technological Progress in the Pharmaceutical IndustryJournal of Economic Perspectives, 1993
- The Australian Guidelines for Subsidisation of PharmaceuticalsPharmacoEconomics, 1992
- Price Regulation, Industry Structure and InnovationPharmacoEconomics, 1992
- A Randomized, Double-Blind Comparison of Sumatriptan and Cafergot in the Acute Treatment of MigraineEuropean Neurology, 1991
- No cure, no pay: an acceptable way of financing fertility treatments?Health Policy, 1989
- Price and Quality Competition in the United States Drug IndustryJournal of Industrial Economics, 1978